Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baoji oral liquid for gastrointestinal influenza (prospective cohort)
ChiCTR2400084754Phase 4Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- May 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of Baoji in Viral Enteritis (2 cohorts), sponsored by Guang'anmen Hospital. Primary endpoint: Gastrointestinal influenza recovery time. Planned start May 2024; status: not yet recruiting.
02
Drugs
Baoji
03
Conditions
Viral Enteritis
Beyond the preview
Go deeper on ChiCTR2400084754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084754.